Interactive exhibition to reduce benzodiazepine use
Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
Consorci Sanitari de l'Alt Penedès i Garraf · NCT06467019
This study tests if an interactive exhibition in a clinic waiting room can help adults use fewer benzodiazepines by educating them about the risks of long-term use.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6410 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf (other) |
| Locations | 1 site (Vilanova i la Geltrú, Barcelona) |
| Trial ID | NCT06467019 on ClinicalTrials.gov |
What this trial studies
This trial aims to assess whether an interactive and informative exhibition in a Primary Care Clinic's waiting room can decrease benzodiazepine consumption among adults. Researchers will compare the usage of benzodiazepines before and after the exhibition is implemented. Participants will engage with materials highlighting the risks associated with chronic benzodiazepine use, while health professionals will also receive a single informative session on the topic.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 99 who attend the Baix-a-Mar Primary Care Center.
Not a fit: Patients with severe mental health diseases or those not assigned to a doctor at the center may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to a significant reduction in benzodiazepine use, improving patient safety and health outcomes.
How similar studies have performed: While there is limited data on similar interactive approaches, previous studies have shown that educational interventions can effectively reduce medication use.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women between 18 and 99 years of age. * Attended at the Baix-a-Mar Primary Care Center during the study period. Exclusion Criteria: * Severe mental health disease * Displaced patients or those who do not have an assigned doctor at the center. * Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Where this trial is running
Vilanova i la Geltrú, Barcelona
- Centro de Salud Vilanova i la Geltrú 3 Baix A Mar — Vilanova i la Geltrú, Barcelona, Spain (RECRUITING)
Study contacts
- Principal investigator: Jordi Milozzi, MD — Centro de Salud Vilanova i la Geltrú 3 Baix A Mar-CSAPG
- Study coordinator: Jordi Milozzi, MD
- Email: jmilozzi@csapg.cat
- Phone: +34 938 10 30 03
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Benzodiazepine-Related Disorders, Benzodiazepines, Deprescriptions